| ADME | Absorption, Distribution, Metabolism, and Excretion |
| ADR | Adverse Drug Reaction |
| ANOVA | Analysis of Variance |
| AUC | Area Under the Curve |
| CI | Confidence Interval |
| CKD | Chronic Kidney Disease |
| CPIC | Clinical Pharmacogenetics Implementation Consortium |
| CYP | Cytochrome P450 |
| DDGI | Drug–Drug–Gene Interaction |
| DDI | Drug–Drug Interaction |
| DOAC | Direct Oral Anticoagulant |
| DPWG | Dutch Pharmacogenetics Working Group |
| eGFR | Estimated glomerular filtration rate |
| HIV | Human Immunodeficiency Virus |
| HLA | Human Leukocyte Antigen |
| INR | International Normalized Ratio |
| NSAID | Non-Steroidal Anti-Inflammatory Drug |
| OATP | Organic Anion Transporting Polypeptide |
| PACE | Program of All-Inclusive Care for the Elderly |
| PBPK | Physiologically Based Pharmacokinetic |
| PET | Positron Emission Tomography |
| P-gp | P-glycoprotein |
| PGx | Pharmacogenomics/Pharmacogenetics |
| PPI | Proton Pump Inhibitor |
| SCAR | Severe Cutaneous Adverse Reaction |
| SNRI | Serotonin–Norepinephrine Reuptake Inhibitor |
| SSRI | Selective Serotonin Reuptake Inhibitor |
| START | Screening Tool to Alert to Right Treatment |
| STOPP | Screening Tool of Older Persons’ Prescriptions |
| TTR | Time in Therapeutic Range |
| UGT | Uridine Diphosphate Glucuronosyltransferase |